Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2010
06/10/2010WO2009136286A3 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
06/10/2010WO2009065561A8 System for delivery into a xcr1 positive cell and uses thereof
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100146653 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
06/10/2010US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145026 Antibody for ADCC And Inducing Cytokine Production
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144639 Use of inhibitors of the egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph) / prostatic hypertrophy
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100143485 Oxycontin controlled release formulations and methods of using same
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143444 Peptides and peptide mimetics to treat pathologies associated with eye disease
06/10/2010US20100143441 Nortriptyline compounds for promoting bone growth
06/10/2010US20100143440 Ul97 inhibitors for treatment of proliferative disorders
06/10/2010US20100143424 Casein nanoparticle
06/10/2010US20100143418 Immunising Against Meningococcal Serogroup Y Using Proteins
06/10/2010US20100143417 Compositions and methods for controlling diseases in animals
06/10/2010US20100143416 Alpha-defensins as anthrax immunotherapeutis
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143414 Pneumococcal serotypes
06/10/2010US20100143413 Apparatus and method for treating a neuromuscular defect
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143411 Method for identification of t-lymphocyte antigens
06/10/2010US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/10/2010US20100143409 Generation of virus-like particles and use as panfilovirus vaccines
06/10/2010US20100143408 Papillomavirus vaccines
06/10/2010US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
06/10/2010US20100143406 Methods of enhancing protein incorporation into virus like particles
06/10/2010US20100143405 Immunotherapy of virus infection
06/10/2010US20100143404 Thiophene derivatives for up-regulating HLA-DM activity
06/10/2010US20100143403 Methods and compositions for vaccination of poultry
06/10/2010US20100143402 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus
06/10/2010US20100143401 Vaccine preventing and/or treating autoimmune diseases
06/10/2010US20100143400 Immunostimulatory Oligonucleotides
06/10/2010US20100143399 Process for manufacturing vaccines
06/10/2010US20100143396 Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides
06/10/2010US20100143395 Material with immunogenicity
06/10/2010US20100143394 Synthetic streptococcus pneumoniae vaccine
06/10/2010US20100143393 Novel influenza m2 vaccines
06/10/2010US20100143392 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
06/10/2010US20100143391 Hapten compounds and compositions and uses thereof
06/10/2010US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
06/10/2010US20100143389 Immunomodulating agent in gut
06/10/2010US20100143388 comprise a Fc region comprising complex N-glycoside-linked sugar chains bound to the Fc region; useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143386 FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
06/10/2010US20100143385 Methods for reducing phosphate absorption
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100143383 Oxgr1 agonists for use in therapies for metabolic disorders
06/10/2010US20100143382 Modulation of rhamm (cd168) for selective adipose tissue development
06/10/2010US20100143381 Lysophosphatidic acid receptor targeting for lung disease
06/10/2010US20100143380 Compositions and methods for macular degeneration
06/10/2010US20100143379 Mif agonists and antagonist and therapeutic uses thereof
06/10/2010US20100143378 Subcutaneous Administration of Anti-Hepatitis B Antibodies
06/10/2010US20100143377 Products for prophylaxis and/or treatment of viral diseases and methods of making and using same
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143375 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
06/10/2010US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
06/10/2010US20100143373 Methods of treating systemic lupus erythematosus
06/10/2010US20100143372 Interferon alpha-induced pharmacodynamic markers
06/10/2010US20100143371 Intrabodies
06/10/2010US20100143370 Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease
06/10/2010US20100143369 Interferon Alpha Receptor I Antibodies And Their Use
06/10/2010US20100143368 Human Antibodies That Bind Cd22 And Uses Thereof
06/10/2010US20100143367 Novel anti-cd98 antibody
06/10/2010US20100143366 Antitumor agent
06/10/2010US20100143365 Methods and materials related to anti-amyloid antibodies
06/10/2010US20100143364 Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143362 LINGO binding molecules and Pharmaceutical Use Thereof
06/10/2010US20100143361 Methods for the treatment of a-beta related disorders and compositions therefor
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143358 Use of Antibody Conjugates
06/10/2010US20100143357 Uses of Mammalian Cytokine; Related Reagents
06/10/2010US20100143356 Therapeutic and diagnostic anti-hsp70 antibodies
06/10/2010US20100143355 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
06/10/2010US20100143354 Triazine dna modifiers
06/10/2010US20100143353 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
06/10/2010US20100143352 Combination therapy for b cell disorders
06/10/2010US20100143351 Anti-Angiogenesis Therapy for the Treatment of Breast Cancer
06/10/2010US20100143350 Combination of a purine-based cdk inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
06/10/2010US20100143349 Humanized anti-rage antibody
06/10/2010US20100143348 OVR115 Antibody Compositions and Methods of Use
06/10/2010US20100143347 Targeting ncca-atp channel for organ protection following ischemic episode
06/10/2010US20100143346 Treatment of Macular Degeneration
06/10/2010US20100143345 Epha2 agonistic monoclonal antibodies and methods of use thereof
06/10/2010US20100143344 Complement inhibition for improved nerve regeneration
06/10/2010US20100143343 Methods and compositions for the treatment of antibody mediated neuropathies
06/10/2010US20100143342 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
06/10/2010US20100143341 Thienopyrimidines for pharmaceutical compositions
06/10/2010US20100143340 Methods and compositions for treating cancer
06/10/2010US20100143339 Methods of treating and preventing colitis involving il-13 and nk-t cells
06/10/2010US20100143338 Treatment of t-cell mediated diseases
06/10/2010US20100143337 Compositions and methods for characterizing and regulating olfactory sensation
06/10/2010US20100143336 Toll-like receptor binding epitope and compositions for binding thereto
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 1823